Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments. read more ​Â
BitMEX co-founder Arthur Hayes opined that the upcoming presidential election is just a distraction from Bitcoin‘s (CRYPTO: BTC) long-term bullish trend. read more ​Â
Latest Ratings for AVGO Date Firm Action From To Mar 2022 Truist Securities Maintains Buy Mar 2022 JP Morgan Maintains Overweight Mar 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for AVGO View the Latest Analyst Ratings read more ​Â
The Michigan State Pension Fund has invested $10 million in Grayscale’s Ethereum ETFs (NYSE:ETHE), making it one of the top holders of the product. read more ​Â
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.